COMP <GO>
SBC vs SRTA // PIOTROSKI F-SCORE QUALITY
SBC Medical Group Holdings Incorporated (NASDAQ) VS. Strata Critical Medical Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: SBC 8
— SRTA 3
▲ PIOTROSKI F-SCORE QUALITY LEADER: SBC
LAST: $5.69 (+4.40%) • MKT CAP: $585.2M
piotroski-score
6/9
LAST: $4.75 (-0.21%) • MKT CAP: $420.2M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SBC VS. SRTA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SBC | SRTA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.30% | 20.90% | +52.40 | SBC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 63.10% | -7.10% | +70.20 | SBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.98% | -13.92% | +17.90 | SBC | /fcf-yield <GO> |
| Operating Margin | 38.90% | -11.30% | +50.20 | SBC | /operating-margins <GO> |
| Net Profit Margin | 29.40% | 21.00% | +8.40 | SBC | /net-margins <GO> |
| Revenue Growth (YoY) | -15.50% | 34.30% | -49.80 | SRTA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.46 | 5.58 | -0.12 | SRTA | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 4/9 | +2.00 | SBC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 36.4 | +15.36 | SBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.7x | 8.6x | +2.10 | SRTA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $585.2M | $420.2M | $165.0M | SBC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SBC REV | SRTA REV | SBC GROSS % | SRTA GROSS % | SBC FCF | SRTA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $173.6M | $197.1M | 73.3% | 20.9% | $23.3M | -$58.5M |
| FY 2024 | $205.4M | $146.8M | 76.0% | 20.2% | $18.0M | -$33.4M |
| FY 2023 | $193.5M | $225.2M | — | — | $50.7M | -$32.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SBC // BETA —
SRTA // BETA —